Global Juvenile Idiopathic Arthritis Diagnostic Market Revenue and CAGR Forecast Analysis 2025–2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Juvenile Idiopathic Arthritis Diagnostic Industry By 2029?
The market size for diagnosing juvenile idiopathic arthritis has experienced robust growth in the past few years. From $4.75 billion in 2024, it is projected to increase to $5.03 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. The substantial growth during the historical period is due in part to the rising incidence of juvenile idiopathic arthritis, heightened awareness of autoimmune diseases in children, earlier detection, enhanced healthcare funding, and an increased emphasis on child healthcare.
In the upcoming years, an upward trajectory is anticipated for the juvenile idiopathic arthritis diagnostic market, with projections suggesting an expansion to $6.27 billion by 2029. This represents a compound annual growth rate (CAGR) of 5.7%. The surge during the predicted period is attributable to factors such as escalating alliances among research institutions, an amplified call for timely and precise diagnostic solutions, and the escalating instances of autoimmune and inflammatory disorders. Further contributing factors are initiatives by government and healthcare organizations as well as the emergence of telemedicine and digital health platforms. The projection period will see major trends including evolutionary technological strides, advancements in diagnostic technologies, tailoring treatment strategies, and innovative diagnostic tools.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23432&type=smp
Which Growth Drivers Are Shaping The Juvenile Idiopathic Arthritis Diagnostic Market Outlook?
The escalating occurrence of autoimmune disorders is anticipated to drive the growth of the juvenile idiopathic arthritis diagnostic market. Autoimmune disorders, where the body’s immune system unintentionally attacks its own healthy cells leading to inflammation, tissue damage, and chronic health issues, are on the rise. The surge in these diseases is ascribed to a complex mix of environmental catalysts, genetic predispositions, and alterations in lifestyle. These disorders can trigger juvenile idiopathic arthritis (JIA) as they induce the immune system to erroneously attack the synovial tissue in joints, resulting in inflammation and damage. For example, data from Versorgungsatlas.de, a German online platform, revealed that in 2022, out of 73,241,305 insured people, 6,304,340 were diagnosed with at least one autoimmune disease, which equates to a raw prevalence rate of 8.61%. Hence, the escalating occurrence of autoimmune disorders is propelling the juvenile idiopathic arthritis diagnostic market’s expansion.
How Is The Global Juvenile Idiopathic Arthritis Diagnostic Market Broken Down By Segment?
The juvenile idiopathic arthritis diagnosticmarket covered in this report is segmented –
1) By Type: Serological Tests; Imaging Tests; Genetic Tests
2) By Technology: Molecular Diagnostics; Immunoassays; Flow Cytometry
3) By Services: Diagnostic Services; Consultation Services; Laboratory Services
4) By Application: Hospital Laboratories; Diagnostic Centres; Research Institutes
Subsegments:
1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing
Which Notable Trends Are Transforming The Juvenile Idiopathic Arthritis Diagnostic Market Outlook?
Leading businesses in the juvenile idiopathic arthritis diagnostic market are engaging in strategic partnerships to broaden their product range, boost research capabilities, and consolidate their global market presence. These strategic partnerships denote cooperative efforts among organizations with the goal of promoting early detection and diagnosis. For example, in November 2024, the Canada-based biotechnology company, Augurex Life Sciences Corp., joined forces with Quest Diagnostics, a US-based diagnostic services company, with the aim of enhancing rheumatoid arthritis (RA) diagnostics and management through the use of a 14-3-3? (eta) biomarker. As part of this partnership, Quest Diagnostics will authenticate and offer a US-based lab-developed test that uses Augurex’s 14-3-3? biomarker. This test aims to detect elevated concentrations of the 14-3-3? protein, a factor associated with rheumatoid arthritis severity, increasing disease intensity and the risk of joint damage.
Who Are The Primary Market Leaders In The Juvenile Idiopathic Arthritis Diagnostic Market?
Major companies operating in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech , Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, Avecon Healthcare.
Access The Complete Report Here:
Which Regional Markets Are Emerging As Key Hubs For The Juvenile Idiopathic Arthritis Diagnostic Market?
North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the juvenile idiopathic arthritis diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23432&type=smp
Browse Through More Reports Similar to the Global Juvenile Idiopathic Arthritis Diagnostic Market 2025, By The Business Research Company
Arthritis Monoclonal Antibodie Global Market Report 2025
Psoriatic Arthritis Treatments Global Market Report 2025
Companion Animal Arthritis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
